PC
MYOV

Pier Capital’s Myovant Sciences Ltd. MYOV Stock Holding History

Pier Capital’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-294,954
Closed -$3.93M – 110
2022
Q1 		$3.93M Sell
294,954
-1,212
-0.4% -$16.3K 0.5% 89
2021
Q4 		$4.61M Buy
296,166
+3,190
+1% +$60.9K 0.49% 91
2021
Q3 		$6.57M Sell
292,976
-7,640
-3% -$168K 0.68% 81
2021
Q2 		$6.84M Sell
300,616
-254,163
-46% -$5.35M 0.69% 87
2021
Q1 		$11.4M Buy
554,779
+150,940
+37% +$3.44M 1.08% 49
2020
Q4 		$11.2M Buy
403,839
+101,049
+33% +$1.97M 1.18% 26
2020
Q3 		$4.25M Buy
+302,790
New +$5.63M 0.62% 90

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pier Capital's MYOV Position: Q2 2022 in Review

Pier Capital sold out of Myovant Sciences Ltd. (MYOV) in Q2 2022, closing a stake of 294,954 shares — an estimated $3.93M sold.

Pier Capital first reported a position in MYOV in Q3 2020 and held it in 7 quarters. The position peaked at $11.4M in Q1 2021. 91 funds tracked by Wall St. Rank hold MYOV as of Q2 2022.

  • Pier Capital reported no remaining Myovant Sciences Ltd. position as of Q2 2022 after selling out during the quarter.
  • Pier Capital sold 294,954 Myovant Sciences Ltd. shares in Q2 2022, an estimated $3.93M.
  • Pier Capital first reported a position in Myovant Sciences Ltd. in Q3 2020 and held it in 7 quarters.
  • Pier Capital's Myovant Sciences Ltd. position peaked at $11.4M in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2022.

Based on Pier Capital's 13F filing for Q2 2022, filed 15 Aug 2022.